- Review
Mouse Systems to Model Hepatitis C Virus Treatment and Associated Resistance
- Ahmed Atef Mesalam,
- Koen Vercauteren and
- Philip Meuleman
While addition of the first-approved protease inhibitors (PIs), telaprevir and boceprevir, to pegylated interferon (PEG-IFN) and ribavirin (RBV) combination therapy significantly increased sustained virologic response (SVR) rates, PI-based triple the...

